Akorn Pharmaceuticals

Akorn Investor Relations

Press Releases

Date Title  
05/20/20 Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success Printer Friendly Version
05/11/20 Akorn Provides First Quarter 2020 Results Printer Friendly Version
04/01/20 Akorn Provides Update on Sale Process Printer Friendly Version
02/26/20 Akorn Provides Fourth Quarter and Full Year 2019 Results Printer Friendly Version
02/12/20 Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its Business Printer Friendly Version
02/10/20 Akorn Continues Negotiations with Lenders Printer Friendly Version